Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma
This study is currently recruiting participants.
Study NCT00773097   Information provided by University of Pittsburgh
First Received: October 15, 2008   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Risk for Colorectal Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
MUC1 - Poly ICLC
Additional drug interventions recognized in this trial
Poly ICLC
More general drug interventions related to this trial
Immunologic Factors
Interferon Inducers
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Pittsburgh
National Cancer Institute (NCI)
The Nathan Arenson Fund


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services